Cargando…

Exploring the Nerve Regenerative Capacity of Compounds with Differing Affinity for PPARγ In Vitro and In Vivo

Damage to peripheral nerves can cause debilitating consequences for patients such as lifelong pain and disability. At present, no drug treatments are routinely given in the clinic following a peripheral nerve injury (PNI) to improve regeneration and remyelination of damaged nerves. Appropriately tar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rayner, Melissa L. D., Kellaway, Simon C., Kingston, Isabel, Guillemot-Legris, Owein, Gregory, Holly, Healy, Jess, Phillips, James B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818498/ https://www.ncbi.nlm.nih.gov/pubmed/36611836 http://dx.doi.org/10.3390/cells12010042

Ejemplares similares

Repurposing Small Molecules to Target PPAR-γ as New Therapies for Peripheral Nerve Injuries
por: Rayner, Melissa L. D., et al.
Publicado: (2021)

Local Administration of Minocycline Improves Nerve Regeneration in Two Rat Nerve Injury Models
por: Guillemot-Legris, Owein, et al.
Publicado: (2023)

Serum neurofilament light chain measurements following nerve trauma
por: Wilcox, Matthew, et al.
Publicado: (2023)

Obesity is associated with changes in oxysterol metabolism and levels in mice liver, hypothalamus, adipose tissue and plasma
por: Guillemot-Legris, Owein, et al.
Publicado: (2016)

Oxysterol levels and metabolism in the course of neuroinflammation: insights from in vitro and in vivo models
por: Mutemberezi, Valentin, et al.
Publicado: (2018)

High-fat diet feeding differentially affects the development of inflammation in the central nervous system
por: Guillemot-Legris, Owein, et al.
Publicado: (2016)

Developing an In Vitro Model to Screen Drugs for Nerve Regeneration
por: RAYNER, MELISSA L. D., et al.
Publicado: (2018)

Phenolic Compounds Inhibit 3T3-L1 Adipogenesis Depending on the Stage of Differentiation and Their Binding Affinity to PPARγ
por: Aranaz, Paula, et al.
Publicado: (2019)

miRNA profile is altered in a modified EAE mouse model of multiple sclerosis featuring cortical lesions
por: Orefice, Nicola S, et al.
Publicado: (2020)

PPARγ in Atherosclerotic Endothelial Dysfunction: Regulatory Compounds and PTMs
por: Luan, Jinwen, et al.
Publicado: (2023)

Structural basis for PPARγ transactivation by endocrine-disrupting organotin compounds
por: Harada, Shusaku, et al.
Publicado: (2015)

Determination of Oxidized Lipids in Commonly Consumed Foods and a Preliminary Analysis of Their Binding Affinity to PPARγ
por: Skinner, Joanna, et al.
Publicado: (2021)

PPARγ in Neuroblastoma
por: Peri, Alessandro, et al.
Publicado: (2008)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
por: Kulkarni, Ajit A., et al.
Publicado: (2012)

Cross Regulation of Sirtuin 1, AMPK, and PPARγ in Conjugated Linoleic Acid Treated Adipocytes
por: Jiang, Shan, et al.
Publicado: (2012)

PPARγ and Apoptosis in Cancer
por: Elrod, Heath A., et al.
Publicado: (2008)

PPARγ, neuroinflammation, and disease
por: Mrak, Robert E, et al.
Publicado: (2004)

Nutraceuticals as Ligands of PPARγ
por: Penumetcha, Meera, et al.
Publicado: (2012)

PPARγ and Cognitive Performance
por: d’Angelo, Michele, et al.
Publicado: (2019)

Selected Extracts of Chinese Herbal Medicines: Their Effect on NF-κB, PPARα and PPARγ and the Respective Bioactive Compounds
por: Rozema, E., et al.
Publicado: (2012)

Phosphorylation of PPARγ Affects the Collective Motions of the PPARγ-RXRα-DNA Complex
por: Lemkul, Justin A., et al.
Publicado: (2015)

Myocardial Expression of PPARγ and Exercise Capacity in Patients after Coronary Artery Bypass Surgery
por: Wojtkowska, Izabela, et al.
Publicado: (2017)

Natural Biomaterials as Instructive Engineered Microenvironments That Direct Cellular Function in Peripheral Nerve Tissue Engineering
por: Powell, Rebecca, et al.
Publicado: (2021)

PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
por: Glazer, Robert I., et al.
Publicado: (2008)

Incredible affinity of Kattosh with PPAR‐γ receptors attenuates STZ‐induced pancreas and kidney lesions evidenced in chemicobiological interactions
por: Rashid, Md. Mamunur, et al.
Publicado: (2022)

Surface Functionalized Magnetic Nanoparticles as a Selective Sorbent for Affinity Fishing of PPAR-γ Ligands from Choerospondias axillaris
por: Chi, Miaomiao, et al.
Publicado: (2022)

Comparative Gene Expression Profiles Induced by PPARγ and PPARα/γ Agonists in Human Hepatocytes
por: Rogue, Alexandra, et al.
Publicado: (2011)

Regenerative Capacity of Macrophages for Remyelination
por: Rawji, Khalil S., et al.
Publicado: (2016)

Nur77 and PPARγ regulate transcription and polarization in distinct subsets of M2-like reparative macrophages during regenerative inflammation
por: Garabuczi, Éva, et al.
Publicado: (2023)

Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
por: Zhang, Li-Song, et al.
Publicado: (2012)

Dibutyltin Compounds Effects on PPARγ/RXRα Activity, Adipogenesis, and Inflammation in Mammalians Cells
por: Milton, Flora A., et al.
Publicado: (2017)

PPARγ and MEK Interactions in Cancer
por: Burgermeister, Elke, et al.
Publicado: (2008)

PPARγ and Proline Oxidase in Cancer
por: Phang, James M., et al.
Publicado: (2008)

The Role of PPARγ in Hepatocellular Carcinoma
por: Borbath, Ivan, et al.
Publicado: (2008)

Nuclear receptor corepressors and PPARγ
por: Cohen, Ronald N.
Publicado: (2006)

PPARγ in Kidney Physiology and Pathophysiology
por: Kiss-Tóth, Éva, et al.
Publicado: (2008)

PPARγ tackles treacherous T cells
por: Leslie, Mitch
Publicado: (2009)

Effects of PPARγ Ligands on Leukemia
por: Tabe, Yoko, et al.
Publicado: (2012)

Gastrointestinal Cytoprotection by PPARγ Ligands
por: Naito, Yuji, et al.
Publicado: (2010)

PPARγ in Inflammatory Bowel Disease
por: Annese, Vito, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_dar7t2egjk5s2qekp0iebvr0ce